GordonDB, DahlJL, MiaskowskiC, McCarbergB, ToddKH, PaiceJA, LipmanAG, BookbinderM, SandersSH, TurkDC, CarrDB. American Pain Society Recommendations for improving the quality of acute and cancer pain management. Arch Intern Med, 2005; 165:1574–1580.
2.
PortenoyRK, FoleyKM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain, 1986; 25:171–186.
3.
KatzNP, AdamsEH, ChilcoatH, ColucciRD, ComerSD, GoliberP, GrudzinskasC, JasinskiD, LandeSD, PassikSD, SchnollSH, SellersE, TraversD, WeissR. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain, 2007; 23:648–660.
4.
PassikSD, TheobaldDE. Managing addiction in advanced cancer patients: Why bother?J Pain Symptom Manage, 2000; 19:229–234.
ButlerSF, BudmanSH, FernandezK, JamisonRN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain, 2004; 112:65–75.
7.
WebsterLR, WebsterRM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Med, 2005; 6:432–442.
8.
MooreTM, JonesT, BrowderJH, DaffronS, PassikSD. A comparison of common screening methods for predicting aberrant behavior among patients receiving opioids for chronic pain management. Pain Med, 2009; 10:1426–1433.
